Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Exercise Interventions for Individuals With Neurological Disorders: A Systematic Review of Systematic Reviews

Lai CH, Chen HC, Liou TH, Li W, Chen SC.

Am J Phys Med Rehabil. 2019 Oct;98(10):921-930. doi: 10.1097/PHM.0000000000001247.

N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease

Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB.

Clin Pharmacol Ther. 2019 Oct;106(4):884-890. doi: 10.1002/cpt.1548. Epub 2019 Jul 17.

Dopamine and eating behavior disorders in Parkinson's disease: A complex recipe

Fernagut PO.

Mov Disord. 2019 Jun;34(6):767-768. doi: 10.1002/mds.27703.

Editor's note: The origin of Parkinson's disease: The importance of environment and lifestyle

Obeso JA.

Mov Disord. 2019 Jun;34(6):799-800. doi: 10.1002/mds.27743.

Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease

Dunn AR, O'Connell KMS, Kaczorowski CC.

Neurosci Biobehav Rev. 2019 Aug;103:73-80. doi: 10.1016/j.neubiorev.2019.06.018. Epub 2019 Jun 14.

An overview of the bioactivity of monacolin K / lovastatin

Xiong Z, Cao X, Wen Q, Chen Z, Cheng Z, Huang X, Zhang Y, Long C, Zhang Y, Huang Z.

Food Chem Toxicol. 2019 Sep;131:110585. doi: 10.1016/j.fct.2019.110585. Epub 2019 Jun 15.

Transcranial brain sonography for Parkinsonian syndromes

Bor-Seng-Shu E, Paschoal FM, Almeida KJ, De Lima Oliveira M, Nogueira RC, Teixeira MJ, Walter U.

J Neurosurg Sci. 2019 Aug;63(4):441-449. doi: 10.23736/S0390-5616.19.04696-4.

The management of risk and investment in cell therapy process development: a case study for neurodegenerative disease

Sebastian S, Hourd P, Chandra A, Williams DJ, Medcalf N.

Regen Med. 2019 May;14(5):465-488. doi: 10.2217/rme-2018-0081. Epub 2019 Jun 18.

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Cenini G, Lloret A, Cascella R.

Oxid Med Cell Longev. 2019 May 9;2019:2105607. doi: 10.1155/2019/2105607. eCollection 2019.

Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis

Tampi RR, Tampi DJ, Young JJ, Balachandran S, Hoq RA, Manikkara G.

World J Psychiatry. 2019 Jun 10;9(3):47-54. doi: 10.5498/wjp.v9.i3.47. eCollection 2019 Jun 10.

Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054

Brys M, Fanning L, Hung S, Ellenbogen A, Penner N, Yang M, Welch M, Koenig E, David E, Fox T, Makh S, Aldred J, Goodman I, Pepinsky B, Liu Y, Graham D, Weihofen A, Cedarbaum JM.

Mov Disord. 2019 Aug;34(8):1154-1163. doi: 10.1002/mds.27738. Epub 2019 Jun 17.

A tale of two patients: Levodopa and creative awakening in parkinson's disease - A qualitative report

Chacko J, George S, Cyriac S, Chakrapani B.

Asian J Psychiatr. 2019 Jun;43:179-181. doi: 10.1016/j.ajp.2019.06.002. Epub 2019 Jun 13.

Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions

Gómez-Gómez ME, Zapico SC.

Int J Mol Sci. 2019 Jun 11;20(11):2842. doi: 10.3390/ijms20112842.

Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach

Velosa A, Neves A, Barahona-Corrêa JB, Oliveira-Maia AJ.

BMJ Case Rep. 2019 Jun 17;12(6):e225840. doi: 10.1136/bcr-2018-225840.

Neurogenesis in Neurodegenerative Diseases: Role of MFG-E8

Cheyuo C, Aziz M, Wang P.

Front Neurosci. 2019 Jun 4;13:569. doi: 10.3389/fnins.2019.00569. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias